Merck KGaA secures second US CRISPR patent
09-04-2020
Merck KGaA secures CRISPR patents in Japan and Singapore
27-11-2019
Juriaan Wossink / shutterstock.com
Merck has added two US patents to its CRISPR-Cas9 patent portfolio, and is already seeking licensing and product development partners, the German company announced yesterday, May 11.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Merck, CRISPR-Cas9, patents, portfolio, US, University of California, Broad Institute, USPTO, IP, gene-editing
